Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Atrial fibrillation and hypertrophic cardiomyopathy: co-existing conditions with additive risks — Kazuo Miyazawa (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Atrial fibrillation and hypertrophic cardiomyopathy: co-existing conditions with additive risks
Shared by
Professor Gregory Lip
University of Liverpool
Atrial fibrillation and hypertrophic cardiomyopathy: co-existing conditions with additive risks
Letter
2017
en
Authors
KM
Kazuo Miyazawa
Professor Gregory Lip
University of Liverpool
Abstract
1 min read
DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2008
Intravenous Cyclophosphamide Therapy in Adults with Henoch-Schönlein Purpura
Jae Il Shin
,
Jae Seung Lee
Article
2006
Advances in Subspace-Based Techniques for Signal Processing and Communications
Kostas Berberidis
,
Benoı̂t Champagne
,
George V. Moustakides
,
H Vincent Vincent Poort
,
Peter Stoica
Article
2006
Correction: Is the Current Management of Severe Sepsis and Septic Shock Really Evidence Based?
Jean Louis Vincent
Article
2021
Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?
Masatoshi Kudo
Article
2010
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
Kenneth F. Schulz
,
Douglas G. Altman
,
David Moher
Discussion(0)
No comments yet. Be the first to comment.